Pharma Journalist -

Alexion Pharmaceuticals, Inc. and Caelum Biosciences announced a collaboration to develop CAEL-101 for light chain (AL) amyloidosis. CAEL-101 is a first-in-class amyloid fibril targeted…
Read More...

Invenra and WARF (Wisconsin Alumni Research Foundation) announced they have entered into a collaboration to discover and develop a bispecific antibody therapeutic for the treatment of…
Read More...

Agenus Inc. announced the upcoming launch of its Biotech Electronic Security Token (BEST), the first digital security offering in healthcare. Tokenization will enable qualified…
Read More...

Takeda Pharmaceutical announced that the pivotal Phase 3 trial of its dengue vaccine candidate met the primary efficacy endpoint. This first analysis of the Tetravalent Immunization…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced a worldwide collaboration and license agreement with MeiraGTx Holdings plc, a clinical-stage gene therapy…
Read More...

Fortress Biotech announced that Caelum Biosciences has signed a strategic agreement with Alexion Pharmaceuticals to advance the development of CAEL-101 for light chain (AL) amyloidosis.…
Read More...

Cryoport, Inc. will celebrate the official opening of its most recent Global Logistics Center, based in Amsterdam, The Netherlands. The ribbon-cutting ceremony will be attended by…
Read More...

The Lubrizol Corporation announces its contract development and manufacturing organization (CDMO), Particle Sciences, a Lubrizol LifeSciences company, is partnering with leading Indian…
Read More...

Lyndra Therapeutics, which is moving toward making daily pills a thing of the past, announced it has raised $55 million in Series B financing, funds it will use for Phase II clinical…
Read More...

Pfizer Inc. and Eli Lilly and Company announced positive top-line results from a Phase 3 study evaluating tanezumab 2.5 mg or 5 mg in patients with moderate-to-severe osteoarthritis…
Read More...